The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.

Thermo Fisher has launched a suite of expanded CRO and CDMO services under its own brand, Accelerator™ Drug Development, intended to serve biotechs and pharmas.

In this resource, learn how operational obstacles can be addressed and to meet industry demand, Explore how pharmaceutical ...

LENEXA, Kan. and MOONACHIE, N.J., Nov. 19, 2024 /PRNewswire/ -- Vantage MedTech, a leading provider of comprehensive design and manufacturing services for medical technology, today announced that Kimb ...

The Oss facility also includes purpose-built automated manufacturing flows, and fully integrated analytical capabilities for characterizing complex nanomedicine formulations. These enhancements allow ...